In the late 1990s, Dawn M. Gross was headed for a prominent career in immunology. As a dual M.D./Ph.D. candidate at Tufts School of Medicine, she worked with scientists Allen Steere and Brigitte Huber and was the sole student ...
Dec 2, 2015
0
4
Researchers at the University of Colorado Anschutz Medical Campus have found that fat cells produced by stem cells from the bone marrow may be linked to chronic illnesses like diabetes, cardiovascular disease, kidney disease ...
Nov 24, 2015
0
1
Mary Leonard, MD, is pointing at a spine MRI scan of a young adult who had a bone marrow transplant in childhood. "That vertebra is compressed," said Leonard, a professor of pediatrics and of medicine who serves as an associate ...
Nov 9, 2015
0
6
A one-year-old girl in Britain has become the first in the world to be treated with "designer" immune cells genetically engineered to reverse her cancer, doctors said Thursday.
Nov 6, 2015
0
321
More than 40 percent of older patients with acute myeloid leukemia (AML) can remain in long-term cancer remission through a modified, less aggressive approach to donor stem cell transplantation, according to the results of ...
Nov 4, 2015
0
11
Drowsy mice make poor stem cell donors, according to a new study by researchers at the Stanford University School of Medicine.
Oct 14, 2015
0
207
Proposed legislation in Wisconsin will have a devastating impact on the ability of researchers to create lifesaving treatments for patients, Robert Golden, dean of the University of Wisconsin-Madison School of Medicine and ...
Sep 25, 2015
0
3
A team of scientists at the Children's Research Institute at UT Southwestern (CRI) has become the first to use a tissue-clearing technique to localize a rare stem cell population, in the process cracking open a black box ...
Sep 24, 2015
0
100
Children with cancer want honest but hopeful information. But giving appropriate information is difficult and improvements are needed for the sake of the child, the siblings and the parents. In a dissertation from Uppsala ...
Sep 21, 2015
0
11
Targeting exhausted immune cells may change the prognosis for patients with acute myeloid leukemia (AML) relapse after a stem cell transplant, according to Penn State College of Medicine researchers.
Sep 10, 2015
0
15
